Re: Adjudication
|
4
|
Resverlogix Corp.
|
Dec 28, 2018 02:52PM
|
Re: AGM
|
4
|
Resverlogix Corp.
|
Dec 17, 2020 11:07AM
|
Zenith AGM Tuesday 12/12 2:45 MT
|
4
|
Zenith Epigenetics
|
Dec 11, 2017 12:06PM
|
Re: The significance of the SSRA
|
4
|
Resverlogix Corp.
|
Jun 20, 2018 10:20AM
|
Re: RVX exposure
|
4
|
Resverlogix Corp.
|
Feb 13, 2016 07:03AM
|
Re: Contest Tally
|
4
|
Resverlogix Corp.
|
Feb 21, 2019 10:11AM
|
Zenith Q4 2017 Events
|
4
|
Zenith Epigenetics
|
Nov 07, 2017 10:13AM
|
Re: New Share Price Contest update to Oct 12th
|
4
|
Resverlogix Corp.
|
Oct 13, 2019 10:28AM
|
Re: p-values : are correct
|
4
|
Resverlogix Corp.
|
Feb 24, 2017 12:03PM
|
Re: 2 events this week
|
4
|
Resverlogix Corp.
|
Mar 06, 2017 10:49PM
|
Re: Question about other indications and inflammatory markers
|
4
|
Resverlogix Corp.
|
Jul 22, 2016 11:00AM
|
Re: Just back from IR,...
|
4
|
Resverlogix Corp.
|
Oct 29, 2019 11:50AM
|
Re: Thought Provoking
|
4
|
Resverlogix Corp.
|
Mar 14, 2018 11:13AM
|
Re: What would a successful BETonMACE Top-Line Data Announcement Look Like?
|
4
|
Resverlogix Corp.
|
Aug 11, 2019 02:18PM
|
Re: Resverlogix Receives US FDA Breakthrough Therapy Designation for Apabetalone
|
4
|
Resverlogix Corp.
|
Feb 03, 2020 09:20AM
|
Re: A few clarifications from IR
|
4
|
Resverlogix Corp.
|
Mar 06, 2019 10:33AM
|
Re: Did IR ever say RVX would be announcing DBL
|
4
|
Resverlogix Corp.
|
Aug 14, 2019 02:18PM
|
Re: 600 patients....doing the math
|
4
|
Resverlogix Corp.
|
Aug 30, 2016 04:52PM
|
Re: Trying to get my head around this
|
4
|
Zenith Epigenetics
|
May 02, 2018 09:15AM
|
Zenith presents at BIO Investor Forum Oct 17th
|
4
|
Zenith Epigenetics
|
Oct 08, 2018 05:39PM
|